mind body natural glp 1 UC Davis Health examines systemic impact of GLP-1–based therapies What Is GLP-1 and Why

Ideal candidates are those with a high BMI, comorbid conditions such as type 2 diabetes, and an elevated cardiovascular risk profile

Continue reading More about tirzepatide Check interactions Compare alternatives Reviews (3,318) Latest FDA alerts (3) Side effects Dosage information During pregnancy Support group Drug class: GLP-1 Drugs Breastfeeding Patient resources Other brands Professional resources Other brands Related treatment guides Further information Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Be Cautious With Kelp

Disclosures: Liang Wen: Nothing to Disclose, Yixiao Yang: Nothing to Disclose, Tingbo Liang: Nothing to Disclose 2639 PREDICTING SURVIVAL AMONG PATIENTS WITH EARLY- TO INTERMEDIATE-STAGE HCC: MIAMI LIVER CANCER ESTIMATOR OF SURVIVAL (MILES) SCORE David Goldberg 1 David Kaplan 2 Binu John 1 Neelima Gaddipati 1 Sirisha Gaddipati 1 Yalda Zarnegarnia 1 Peter Reese 2 Catherine Blandon 1 , 1 University of Miami, 2 University of Pennsylvania Background: Staging and prognostication of hepatocellular carcinoma (HCC) differs from other cancers because it must account for tumor burden as well as function of the diseased organ (i.e., liver)